The ability of fibrinogen fragments to support ADP-induced platelet aggregation.
Explore the source record for details and available documents.
Adenosine Diphosphate↗
Biomedical subjects
Publications and source records attributed to M Mahmoud.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A new drug, NSC-140117, was used in the management of 15 patients who had late bronchogenic carcinoma and were unable to receive surgical or radiotherapeutic treatment. Good responses in the form of 90% shrinkage in the size of the lesionswere encountered in nine patients (60%). Response is still being maintained from 6 months to 1.5 years after the start of therapy. No toxic effects, including hematopoietic toxicity, were encountered.